Target intelligence / Profile preview

ADP-ribosylation factor-like protein 10 (ARL10)

Target
ARL10
Molecular classification
Small GTPase, ARF-like GTPase, Other
01

Overview

ADP-ribosylation factor-like protein 10 (ARL10) is a member of the ARF-like family of small GTPases, functioning as a molecular switch by cycling between GDP- and GTP-bound forms. ARL10 is primarily localized to mitochondria, peroxisomes, endoplasmic reticulum, and the nucleus, and contains a unique N-terminal transmembrane domain critical for its mitochondrial targeting[1]. Its biological functions, identified through proteomic mapping studies, suggest roles in regulating mitophagy, mitochondrial and peroxisome organization, protein trafficking, vacuolar transport, cilium and centrosome organization, and TOR (Target of Rapamycin) signaling[1]. While it is a protein coding gene, with predicted GTP and GTPase binding activity, its clinical or therapeutic targeting potential is not established. ARL10 mutations or dysregulation have been associated with certain cancers, such as mucinous stomach adenocarcinoma, although its detailed involvement in disease mechanisms remains undercharacterized[3].

Other names
ARL10AADP-ribosylation factor-like 10AADP-ribosylation factor-like membrane-associated protein
02

Biological functions

GTP bindingGTPase activityOrganelle localizationMitochondrial organizationMitophagyProtein transport to peroxisomesRegulation of cilium organizationMicrotubule-based transportTOR signaling
03

Disease associations

Cancer (notably mucinous stomach adenocarcinoma)Other

Beyond the preview

Go deeper on ADP-ribosylation factor-like protein 10 (ARL10).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on ADP-ribosylation factor-like protein 10 (ARL10).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call